Brian M Slomovitz Selected Research

Brian M Slomovitz Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 03/2002
20	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 10/2003
11	Ovarian Neoplasms (Ovarian Cancer) 10/2022 - 01/2006
8	Carcinoma (Carcinomatosis) 01/2023 - 10/2003
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021 - 06/2005
3	Ovarian Epithelial Carcinoma 01/2023 - 03/2007
3	Microsatellite Instability 01/2023 - 11/2005
3	Fallopian Tube Neoplasms 01/2022 - 12/2006
3	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 06/2005
3	Hyperplasia 11/2011 - 10/2003
3	Neoplasm Metastasis (Metastasis) 12/2006 - 08/2004
2	Vulvar Neoplasms (Vulvar Cancer) 12/2023 - 08/2015
2	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2004
2	Disease Progression 01/2022 - 07/2008
2	Leiomyosarcoma 02/2019 - 06/2005
2	Endometrial Hyperplasia 11/2005 - 10/2003
1	Fatigue 01/2023
1	Alopecia (Baldness) 01/2023
1	Nausea 01/2023
1	Female Genital Diseases 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Uterine Neoplasms (Uterine Cancer) 01/2022
1	Anemia 11/2020
1	Constipation 11/2020
1	Diarrhea 11/2020
1	Neutropenia 11/2020
1	Abdominal Pain (Pain, Abdominal) 11/2020
1	COVID-19 01/2020
1	Endometriosis 10/2019
1	Fever (Fevers) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Mucositis 01/2019
1	Choriocarcinoma 01/2017
1	Leiomyoma (Uterine Fibroids) 02/2015
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2012
1	Adenocarcinoma 11/2011
1	Leiomyomatosis 12/2009
1	Cicatrix (Scar) 01/2009

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 10/2022 - 07/2008
5	Letrozole (Femara)FDA LinkGeneric 01/2022 - 07/2008
5	Everolimus FDA Link 01/2022 - 12/2010
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 06/2006
4	Phosphotransferases (Kinase)IBA 11/2020 - 10/2004
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2020
3	Estrogen ReceptorsIBA 02/2019 - 10/2003
3	TOR Serine-Threonine KinasesIBA 05/2014 - 05/2008
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2010 - 03/2007
3	TensinsIBA 12/2010 - 03/2007
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 12/2020
2	pembrolizumabIBA 01/2022 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2020 - 11/2020
2	tisotumab vedotinIBA 01/2020 - 01/2019
2	MTOR InhibitorsIBA 05/2014 - 05/2008
2	Imatinib Mesylate (Gleevec)FDA Link 06/2005 - 10/2004
2	Tyrosine (L-Tyrosine)FDA Link 06/2005 - 10/2004
2	Hormones (Hormone)IBA 10/2003 - 03/2002
1	dostarlimabIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022
1	cediranib (AZD2171)IBA 10/2022
1	olaparibIBA 10/2022
1	N 30IBA 01/2022
1	niraparibIBA 01/2022
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	balstilimabIBA 09/2021
1	FANG vaccineIBA 12/2020
1	Tyrosine Kinase InhibitorsIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Drug CombinationsIBA 11/2020
1	Gefitinib (Iressa)FDA Link 11/2020
1	Cetuximab (Erbitux)FDA Link 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Messenger RNA (mRNA)IBA 11/2020
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Thromboplastin (Tissue Factor)IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2012
1	taxaneIBA 07/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2008
1	WortmanninIBA 05/2008
1	Sirolimus (Rapamycin)FDA Link 05/2008
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 05/2008

Therapy/Procedure

15	Therapeutics 01/2023 - 08/2004
8	Drug Therapy (Chemotherapy) 01/2023 - 11/2008
6	Hysterectomy 01/2022 - 01/2006
4	Immunotherapy 01/2023 - 12/2020
4	Lymph Node Excision (Lymph Node Dissection) 08/2015 - 08/2006
3	Laparotomy 02/2015 - 08/2006
3	Length of Stay 11/2008 - 08/2006
2	Salpingo-oophorectomy 01/2016 - 01/2006
2	Radiotherapy 11/2008 - 06/2005
2	Colostomy 11/2008 - 10/2008
1	Vulvectomy 12/2023
1	Aftercare (After-Treatment) 11/2020
1	Cesarean Section (Caesarean Section) 10/2019
1	Morcellation 02/2015
1	Adjuvant Chemotherapy 05/2013